Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Marc Braunstein

Myeloma · NYU Grossman Long Island

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. William Gradishar

Breast Oncology · NU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SUDr. Saad Usmani
    Leading Voice

    Dr. Saad Usmani

    Hematology & Oncology · Myeloma
    Memorial Sloan Kettering Cancer Center
    saad

    Research

    A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma

    2026

    Via Haematologica

    Research

    Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma

    2026

    Via Future Oncol

    Research

    Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma

    2026

    Via Blood Cancer J

    Research

    Patterns and perceptions of supplement use among patients with plasma cell disorders

    2026

    Via Blood Cancer J

    Research

    Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma

    2026

    Via Blood Cancer J

    Research

    International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas

    2026

    Via J Clin Oncol

    Research

    Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era

    2026

    Via Haematologica

    Research

    The EF1α promoter of cilta-cel drives a highly effective GZMK(+) transcriptional program

    2026

    Via Nat Commun

    Research

    Dynamic risk stratification in smoldering multiple myeloma: Integrating evolving biomarkers with the 2/20/20 Model

    2026

    Via Hemasphere

    Research

    Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool

    2026

    Via Clin Cancer Res

    Research

    MAIA frailty subgroup analysis: long-term follow-up with daratumumab plus lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma

    2026

    Via Leukemia

    Research

    T-cell-redirecting therapies in early relapsed multiple myeloma: a systematic review and network meta-analysis

    2026

    Via J Hematol Oncol

    Research

    Population Pharmacokinetic Estimation of Melphalan Exposure Predicts Disease Control and Toxicity After Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

    2026

    Via Transplant Cell Ther

    Research

    Beyond binary: graded frailty assessment and outcomes after CAR-T cell therapy in relapsed/refractory multiple myeloma

    2026

    Via Blood Cancer J

    Research

    Modeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone

    2026

    Via J Clin Oncol